The aim of the study is to validate the value of value of peripheral blood protein biomarkers in colorectal cancer screening, and to identify new ones
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
350
Patient aged 50 years or older referred for screening colonoscopy after a positive fecal immunochemical test or for endoscopic resection of a previously identified suspicious colorectal lesion will have a blood sampling for biomarkers detection
Clinique du Cèdre
Bois-Guillaume, France
Caen University Hospital
Caen, France
Dijon University Hospital
Dijon, France
Number of patient with advanced neoplasia at colonoscopy
Time frame: Day 1
Number of patient with presence of best isolated serum biomarkers selected from different candidates
Time frame: Day 1
Number of patient with presence of other isolated serum biomarkers selected from different candidates
Time frame: Day 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.